March 26, 2025

Health Supplements

Health Supplements make us strong and powerful

Brain Health Supplements Market Size to Reach a Valuation of US$ 20.01 Billion by 2031, Driven by Increasing Mental Health Awareness

Brain Health Supplements Market Size to Reach a Valuation of US$ 20.01 Billion by 2031, Driven by Increasing Mental Health Awareness

Brain health supplements market to register a CAGR of 11.7% during 2023-2031. Key players are Danone SA, Health Via Modern Nutrition Inc., LIQUID HEALTH, INC., Natural Factors, Unilever PLC, Peak Nootropics, Purelife Bioscience Co., Ltd., Quincy Bioscience, Procera Health, Harbin Pharmaceutical Group Co., Ltd.

NEW YORK, Feb. 25, 2025 /PRNewswire/ — According to a new comprehensive report from The Insight Partners, the global brain health supplements market is growing significantly owing to the rising prevalence of major depressive disorders (MDD).

The_Insight_Partners_Logo
The_Insight_Partners_Logo

The brain health supplements market report comprises a detailed analysis of various dosage forms of brain health supplements and their potential use in improving sleep and recovery, promoting anti-aging and longevity, as well as gaining attention and focus, which are expected to drive market growth in the coming years. The report runs an in-depth analysis of market trends, key players, and future opportunities.

For More Information and To Stay Updated on The Latest Developments in The Brain Health Supplements Market, Download The Sample Pages: 

Overview of Report Findings

Market Growth: The brain health supplements market is expected to reach US$ 20.01 billion by 2031 from US$ 8.24 billion in 2023; it is expected to register a CAGR of 11.7% during the forecast period. The brain health supplement market growth is attributed to growing public awareness of mental health conditions such as depression, anxiety, and attention deficit disorders. Furthermore, the growing popularity of natural and herbal health products is expected to support the market expansion during the forecast period. R&D activity in the brain health supplement sector is rising owing to the increasing inclination toward multi-efficacy medications that can reduce anxiety, improve brain function, raise energy, and act as antidepressants. Furthermore, the growing desire for athletes to increase their brain efficacy is anticipated to create growth prospects in the market.

Growing Prevalence of Major Depressive Disorders to Favor Market: Depression is a mental health condition different from normal mood fluctuations and temporary emotional responses. Treatments such as medications and psychological treatments, along with general measures such as relaxation techniques, help in recovering from this condition. Different treatment options are often combined to treat depression. If depression is recurrent with moderate or severe intensity, it may become a severe health issue. According to estimates by the (World Health Organization) WHO, 5% of adults globally (i.e. ~280 million) suffer from depression. Cases of chronic depression are increasing in Europe. According to Eurostat, 7.2% of European Union (EU) citizens had chronic depression in 2019. The prevalence of depression is higher in Asia Pacific compared to the rest of the world. According to the National Centre for Biotechnology Information (NCBI), there is growing evidence about the role of nutrients in mental health. The adequate consumption of nutrients contributes to better overall health and mental health. Hence, the optimum supply of nutrients as adjunctive therapy to antidepressant treatment is essential for adequate brain functioning. Thus, the growing prevalence of major depressive disorders is driving the growth of the brain health supplements market.

link

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © All rights reserved. | Newsphere by AF themes.